CEBPG promotes acute myeloid leukemia progression by enhancing EIF4EBP1.

You JiangShui-Yan WuYan-Ling ChenZi-Mu ZhangYan-Fang TaoYi XieXin-Mei LiaoXiao-Lu LiGen LiDi WuHai-Rong WangRan ZuoHai-Bo CaoJing-Jing PanJuan-Juan YuSi-Qi JiaZheng ZhangXin-Ran ChuYong-Ping ZhangChen-Xi FengJian-Wei WangShao-Yan HuZhi-Heng LiJian PanFang FangJun Lu

Published in: Cancer cell international (2021)

In summary, we systematically explored the molecular characteristics of CEBPG in AML and identified CEBPG as a potential therapeutic target for AML patients. Our findings provide novel insights into the pathophysiology of AML and indicate a key role for CEBPG in promoting AML progression.

Keyphrases

acute myeloid leukemia
allogeneic hematopoietic stem cell transplantation
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
patient reported outcomes
single molecule
patient reported
human health